Biotechnology
The Biotechnology industry has a total of 585 stocks, with a combined market cap of $1.22 trillion and total revenue of $109.76 billion.
Market Cap
1.22T
Revenue
109.76B
Profits
-40.61B
PE Ratio
n/a
Profit Margin
-37.00%
Dividend Yield
0.04%
586 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.16B | 0.90% | 1,252,858 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 66.74B | 0.63% | 708,346 | 14.92B |
| 3 | ARGX | argenx SE | 57.28B | -0.69% | 324,066 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 40.23B | 0.25% | 1,288,030 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 36.28B | 1.13% | 1,150,933 | 4.29B |
| 6 | ONC | BeOne Medicines AG | 36.23B | -0.27% | 346,473 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 33.88B | -0.32% | 2,114,314 | 2.44B |
| 8 | ROIV | Roivant Sciences Ltd. | 25.18B | -0.26% | 4,043,202 | 8.26M |
| 9 | INCY | Incyte Corporation | 23.51B | 0.84% | 1,207,106 | 5.36B |
| 10 | INSM | Insmed Incorporated | 23.18B | -0.46% | 1,908,229 | 819.56M |
| 11 | BNTX | BioNTech SE | 22.59B | -2.97% | 886,018 | 3.23B |
| 12 | MRNA | Moderna, Inc. | 21.45B | -5.17% | 4,427,773 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.56B | -1.03% | 1,676,218 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.74B | 0.47% | 390,363 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.47B | 1.31% | 2,058,261 | 579.96M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.95B | -0.39% | 538,211 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 13.92B | -0.50% | 1,837,908 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.55B | 0.21% | 147,385 | 1.13B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.40B | -0.22% | 461,840 | 708.24M |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.06B | -1.36% | 1,825,094 | 622.01M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.47B | 0.78% | 1,937,645 | 3.24B |
| 22 | TECH | Bio-Techne Corporation | 11.16B | -0.24% | 2,061,615 | 1.21B |
| 23 | ABVX | ABIVAX Société Anonyme | 11.07B | -4.16% | 950,959 | 5.67M |
| 24 | CYTK | Cytokinetics, Incorporated | 10.96B | -1.44% | 1,848,760 | 105.82M |
| 25 | SMMT | Summit Therapeutics Inc. | 10.90B | -8.81% | 8,153,726 | - |
| 26 | CORT | Corcept Therapeutics Incorporated | 10.24B | -1.34% | 1,003,970 | 769.10M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.01% | 558,218 | - |
| 28 | KRYS | Krystal Biotech, Inc. | 9.88B | 2.35% | 520,338 | 417.30M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 9.72B | 1.35% | 1,661,094 | 1.51B |
| 30 | IONS | Ionis Pharmaceuticals, Inc. | 9.35B | 1.22% | 3,094,732 | 1.06B |
| 31 | KYMR | Kymera Therapeutics, Inc. | 9.10B | 0.17% | 585,216 | 51.48M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 9.07B | 0.90% | 282,678 | 7.46M |
| 33 | SYRE | Spyre Therapeutics, Inc. | 8.98B | 2.14% | 810,830 | - |
| 34 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.83B | 0.10% | 2,344,320 | 18.07M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 8.75B | 0.50% | 298,401 | 74.06M |
| 36 | IMVT | Immunovant, Inc. | 8.13B | 0.10% | 727,071 | - |
| 37 | TGTX | TG Therapeutics, Inc. | 7.94B | 0.97% | 1,431,807 | 700.35M |
| 38 | PCVX | Vaxcyte, Inc. | 7.89B | -1.76% | 1,120,739 | - |
| 39 | IBRX | ImmunityBio, Inc. | 7.44B | -4.05% | 8,524,632 | 140.98M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.00B | -0.55% | 467,132 | 217.17M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 6.89B | -1.16% | 516,939 | 569.61M |
| 42 | COGT | Cogent Biosciences, Inc. | 6.80B | -1.19% | 1,593,418 | - |
| 43 | ERAS | Erasca, Inc. | 6.63B | -1.19% | 3,176,641 | - |
| 44 | PTCT | PTC Therapeutics, Inc. | 6.37B | -2.08% | 838,163 | 827.11M |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.32B | - | 528,927 | 7.50M |
| 46 | CGON | CG Oncology, Inc. | 6.11B | -2.53% | 368,758 | 5.07M |
| 47 | BLTE | Belite Bio, Inc | 6.03B | -1.87% | 172,383 | - |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 5.95B | -0.54% | 277,027 | 274.48M |
| 49 | DFTX | Definium Therapeutics, Inc. | 5.73B | 0.56% | 1,118,179 | - |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.71B | -3.66% | 838,668 | - |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.68B | -0.88% | 827,623 | 1.34M |
| 52 | ORKA | Oruka Therapeutics, Inc. | 5.56B | 0.23% | 579,221 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.33B | 1.20% | 1,228,530 | 536.20M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.58B | -2.08% | 1,419,474 | 4.10M |
| 55 | MANE | Veradermics, Incorporated | 4.58B | -5.48% | 533,152 | - |
| 56 | DYN | Dyne Therapeutics, Inc. | 4.56B | 2.30% | 5,066,096 | - |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.39B | 3.95% | 1,027,994 | - |
| 58 | CAI | Caris Life Sciences, Inc. | 4.39B | -0.83% | 4,932,090 | 907.29M |
| 59 | LEGN | Legend Biotech Corporation | 4.30B | -5.57% | 1,693,895 | 1.14B |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 4.25B | 0.04% | 1,046,975 | 1.10B |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.04B | -1.70% | 1,837,541 | - |
| 62 | CELC | Celcuity Inc. | 4.03B | -6.47% | 1,294,424 | - |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.02B | -3.40% | 2,039,927 | 10.68M |
| 64 | PBLS | Parabilis Medicines, Inc. | 3.98B | -4.66% | 349,542 | - |
| 65 | TNGX | Tango Therapeutics, Inc. | 3.85B | -2.99% | 2,461,337 | 56.99M |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.70B | 0.27% | 368,754 | - |
| 67 | DNLI | Denali Therapeutics Inc. | 3.67B | -1.32% | 1,162,860 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.57B | -4.41% | 1,230,517 | 236.00M |
| 69 | ALMS | Alumis Inc. | 3.57B | -1.06% | 1,164,912 | 8.40M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.49B | -3.31% | 655,405 | - |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.48B | -2.76% | 83,019 | 803.79M |
| 72 | NAMS | NewAmsterdam Pharma Company N.V. | 3.47B | -2.98% | 1,093,346 | 22.57M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.42B | 0.07% | 819,219 | 415.62M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 3.37B | -2.29% | 901,709 | 225.27M |
| 75 | MBX | MBX Biosciences, Inc. | 2.95B | -2.47% | 500,908 | - |
| 76 | IRON | Disc Medicine, Inc. | 2.83B | -2.29% | 403,318 | - |
| 77 | CLDX | Celldex Therapeutics, Inc. | 2.77B | -0.40% | 639,219 | 865.00K |
| 78 | QURE | uniQure N.V. | 2.68B | -1.17% | 1,345,746 | 18.09M |
| 79 | ATAI | AtaiBeckley Inc. | 2.66B | 0.14% | 6,965,932 | 3.49M |
| 80 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | -0.44% | 1,495,613 | 670.00M |
| 81 | KOD | Kodiak Sciences Inc. | 2.59B | 0.95% | 512,890 | - |
| 82 | VERA | Vera Therapeutics, Inc. | 2.54B | -2.48% | 785,912 | - |
| 83 | TARS | Tarsus Pharmaceuticals, Inc. | 2.52B | 0.14% | 444,355 | 535.08M |
| 84 | IMNM | Immunome, Inc. | 2.52B | 0.91% | 615,225 | 4.02M |
| 85 | BEAM | Beam Therapeutics Inc. | 2.50B | -3.13% | 1,810,181 | 164.01M |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.49B | 2.07% | 1,652,093 | - |
| 87 | NRIX | Nurix Therapeutics, Inc. | 2.43B | -1.52% | 833,253 | 36.77M |
| 88 | NKTR | Nektar Therapeutics | 2.39B | 1.97% | 835,967 | 55.63M |
| 89 | PHVS | Pharvaris N.V. | 2.39B | 2.74% | 255,706 | - |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | -1.07% | 648,860 | - |
| 91 | VCEL | Vericel Corporation | 2.30B | - | 360,247 | 292.09M |
| 92 | KLRA | Kailera Therapeutics, Inc. | 2.29B | 1.67% | 672,853 | - |
| 93 | NUVB | Nuvation Bio Inc. | 2.24B | -1.08% | 6,140,390 | 143.05M |
| 94 | IOVA | Iovance Biotherapeutics, Inc. | 2.23B | -2.73% | 9,431,084 | 285.61M |
| 95 | SLS | SELLAS Life Sciences Group, Inc. | 2.23B | -8.27% | 6,728,973 | - |
| 96 | COAG | Hemab Therapeutics Holdings, Inc. | 2.21B | 3.23% | 779,646 | - |
| 97 | AGIO | Agios Pharmaceuticals, Inc. | 2.16B | 0.22% | 890,109 | 66.05M |
| 98 | ZLAB | Zai Lab Limited | 2.16B | -2.34% | 477,785 | 453.28M |
| 99 | BHVN | Biohaven Ltd. | 2.16B | -2.25% | 1,718,080 | - |
| 100 | VRDN | Viridian Therapeutics, Inc. | 2.13B | 0.05% | 1,514,008 | 70.92M |
| 101 | SION | Sionna Therapeutics, Inc. | 2.06B | 3.72% | 654,931 | - |
| 102 | HRMY | Harmony Biosciences Holdings, Inc. | 2.04B | -1.34% | 585,338 | 899.11M |
| 103 | NBTX | Nanobiotix S.A. | 2.02B | 0.38% | 103,746 | 38.27M |
| 104 | MESO | Mesoblast Limited | 2.02B | -4.79% | 188,256 | 65.38M |
| 105 | URGN | UroGen Pharma Ltd. | 2.00B | -3.60% | 421,251 | 140.49M |
| 106 | PVLA | Palvella Therapeutics, Inc. | 1.98B | -3.63% | 184,281 | - |
| 107 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | 0.72% | 792,970 | 298.30M |
| 108 | RAPP | Rapport Therapeutics, Inc. | 1.95B | -1.69% | 269,624 | 20.00M |
| 109 | PGEN | Precigen, Inc. | 1.93B | -2.53% | 2,866,849 | 31.60M |
| 110 | GLUE | Monte Rosa Therapeutics, Inc. | 1.92B | -1.09% | 870,562 | 42.95M |
| 111 | ZBIO | Zenas BioPharma, Inc. | 1.92B | -1.94% | 558,949 | 10.00M |
| 112 | ADMA | ADMA Biologics, Inc. | 1.92B | -1.19% | 2,341,122 | 509.86M |
| 113 | GHRS | GH Research PLC | 1.87B | -1.27% | 163,862 | - |
| 114 | OCUL | Ocular Therapeutix, Inc. | 1.86B | -1.33% | 1,166,170 | 52.04M |
| 115 | KARD | Kardigan, Inc. | 1.85B | -4.29% | 157,632 | - |
| 116 | FTRE | Fortrea Holdings Inc. | 1.85B | 0.10% | 1,343,363 | 2.71B |
| 117 | SNDX | Syndax Pharmaceuticals, Inc. | 1.84B | -1.89% | 1,229,045 | 217.17M |
| 118 | LKFT | Lakefront Biotherapeutics NV | 1.84B | -1.00% | 167,205 | 1.20B |
| 119 | STOK | Stoke Therapeutics, Inc. | 1.82B | -1.18% | 441,821 | 32.08M |
| 120 | TYRA | Tyra Biosciences, Inc. | 1.82B | -0.55% | 645,856 | - |
| 121 | IMCR | Immunocore Holdings plc | 1.78B | -1.44% | 530,377 | 412.81M |
| 122 | BCAX | Bicara Therapeutics Inc. | 1.78B | -2.56% | 481,656 | - |
| 123 | DMRA | Damora Therapeutics, Inc. | 1.77B | -1.20% | 564,861 | - |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.77B | -5.32% | 1,810,583 | 7.47M |
| 125 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.75B | -4.11% | 1,911,374 | 204.73M |
| 126 | GENB | Generate Biomedicines, Inc. | 1.72B | -3.11% | 321,443 | 30.30M |
| 127 | AAPG | Ascentage Pharma Group International | 1.66B | -5.38% | 4,578 | 82.08M |
| 128 | MPLT | MapLight Therapeutics, Inc. | 1.66B | 3.78% | 547,342 | - |
| 129 | SRPT | Sarepta Therapeutics, Inc. | 1.66B | -1.26% | 2,138,874 | 2.18B |
| 130 | ZYME | Zymeworks Inc. | 1.64B | -1.12% | 272,310 | 81.26M |
| 131 | ABCL | AbCellera Biologics Inc. | 1.62B | -6.35% | 6,271,189 | 79.21M |
| 132 | ANAB | AnaptysBio, Inc. | 1.60B | -1.38% | 486,834 | 232.39M |
| 133 | INVA | Innoviva, Inc. | 1.58B | 1.13% | 550,441 | 420.69M |
| 134 | MLTX | MoonLake Immunotherapeutics | 1.57B | -1.76% | 650,856 | - |
| 135 | RXRX | Recursion Pharmaceuticals, Inc. | 1.57B | -1.66% | 16,530,380 | 66.41M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.53B | -0.04% | 166,025 | 20.00M |
| 137 | NTLA | Intellia Therapeutics, Inc. | 1.50B | -3.33% | 3,462,561 | 66.09M |
| 138 | SEPN | Septerna, Inc. | 1.49B | -1.11% | 242,034 | 72.26M |
| 139 | AVBP | ArriVent BioPharma, Inc. | 1.48B | 0.60% | 474,964 | - |
| 140 | VIR | Vir Biotechnology, Inc. | 1.47B | -6.96% | 2,149,544 | 65.50M |
| 141 | XNCR | Xencor, Inc. | 1.44B | -0.46% | 632,668 | 97.36M |
| 142 | SVRA | Savara Inc. | 1.40B | -4.17% | 1,548,718 | - |
| 143 | FBRX | Forte Biosciences, Inc. | 1.34B | -8.24% | 574,456 | - |
| 144 | AKTS | Aktis Oncology, Inc. | 1.32B | -0.50% | 193,793 | 8.28M |
| 145 | ABSI | Absci Corporation | 1.28B | -6.32% | 2,594,613 | 1.84M |
| 146 | MNKD | MannKind Corporation | 1.28B | 6.17% | 9,444,208 | 360.78M |
| 147 | ORIC | ORIC Pharmaceuticals, Inc. | 1.25B | 11.11% | 3,613,159 | - |
| 148 | ARDX | Ardelyx, Inc. | 1.24B | -1.95% | 1,719,518 | 427.68M |
| 149 | IMTX | Immatics N.V. | 1.24B | -2.26% | 290,487 | 43.00M |
| 150 | TRAX | First Tracks Biotherapeutics, Inc. | 1.24B | -5.63% | 495,335 | - |
| 151 | AVLN | Avalyn Pharma Inc. | 1.24B | -5.99% | 139,579 | - |
| 152 | NVAX | Novavax, Inc. | 1.23B | -4.73% | 3,178,301 | 596.34M |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.20B | -4.06% | 164,938 | 1.30M |
| 154 | JBIO | Jade Biosciences, Inc. | 1.19B | 2.34% | 684,561 | - |
| 155 | CAPR | Capricor Therapeutics, Inc. | 1.14B | -0.66% | 2,469,809 | 11.13M |
| 156 | SPTX | Seaport Therapeutics, Inc. | 1.13B | -3.83% | 53,530 | - |
| 157 | DRTS | Alpha Tau Medical Ltd. | 1.13B | -5.59% | 364,525 | - |
| 158 | WVE | Wave Life Sciences Ltd. | 1.12B | 0.52% | 2,067,115 | 71.80M |
| 159 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | -4.46% | 955,748 | - |
| 160 | MGTX | MeiraGTx Holdings plc | 1.09B | -2.73% | 497,312 | 79.76M |
| 161 | CGEM | Cullinan Therapeutics, Inc. | 1.05B | -1.04% | 316,644 | - |
| 162 | VOR | Vor Biopharma Inc. | 1.04B | 1.48% | 638,804 | - |
| 163 | ANRO | Alto Neuroscience, Inc. | 1.04B | -0.26% | 295,573 | - |
| 164 | IVA | Inventiva S.A. | 1.03B | -1.11% | 667,373 | 7.94M |
| 165 | EYPT | EyePoint, Inc. | 1.02B | -2.25% | 1,468,693 | 7.61M |
| 166 | OLMA | Olema Pharmaceuticals, Inc. | 1.02B | -0.34% | 806,830 | - |
| 167 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | -0.43% | 1,681,849 | 69.64M |
| 168 | LBRX | LB Pharmaceuticals Inc | 1.00B | 1.13% | 333,822 | - |
| 169 | AVTX | Avalo Therapeutics, Inc. | 975.53M | 3.83% | 800,235 | 59.00K |
| 170 | SANA | Sana Biotechnology, Inc. | 953.68M | -0.93% | 2,381,132 | - |
| 171 | JANX | Janux Therapeutics, Inc. | 934.89M | -2.48% | 550,012 | 13.73M |
| 172 | KURA | Kura Oncology, Inc. | 922.37M | -0.57% | 1,137,952 | 71.64M |
| 173 | GERN | Geron Corporation | 910.96M | -2.07% | 3,292,710 | 196.12M |
| 174 | PHAT | Phathom Pharmaceuticals, Inc. | 908.68M | -1.38% | 936,449 | 204.89M |
| 175 | ODTX | Odyssey Therapeutics, Inc. | 893.40M | 5.60% | 161,438 | 1.06M |
| 176 | PHAR | Pharming Group N.V. | 886.13M | -4.21% | 5,373 | 369.49M |
| 177 | TBPH | Theravance Biopharma, Inc. | 873.82M | - | 652,200 | 109.78M |
| 178 | ABUS | Arbutus Biopharma Corporation | 865.22M | -2.01% | 876,893 | 191.45M |
| 179 | ANNX | Annexon, Inc. | 855.26M | -1.51% | 2,733,391 | - |
| 180 | REPL | Replimune Group, Inc. | 814.45M | -7.27% | 3,267,434 | - |
| 181 | DBVT | DBV Technologies S.A. | 801.87M | -1.66% | 190,911 | 5.04M |
| 182 | AURA | Aura Biosciences, Inc. | 777.61M | -2.08% | 325,828 | - |
| 183 | SLDB | Solid Biosciences Inc. | 770.86M | -1.88% | 1,088,345 | - |
| 184 | TENX | Tenax Therapeutics, Inc. | 742.36M | -0.75% | 1,155,071 | - |
| 185 | MNPR | Monopar Therapeutics Inc. | 735.99M | 3.95% | 229,795 | - |
| 186 | DSGN | Design Therapeutics, Inc. | 735.74M | 1.29% | 417,044 | - |
| 187 | CLYM | Climb Bio, Inc. | 735.23M | 0.63% | 665,913 | - |
| 188 | ACRS | Aclaris Therapeutics, Inc. | 730.44M | -4.56% | 760,669 | 8.37M |
| 189 | FTH | Faeth Therapeutics, Inc. | 729.28M | 1.91% | 129,147 | - |
| 190 | OMER | Omeros Corporation | 708.55M | -4.77% | 799,038 | 9.89M |
| 191 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 706.54M | 1.15% | 186,153 | - |
| 192 | CTMX | CytomX Therapeutics, Inc. | 705.36M | -2.70% | 1,519,806 | 35.54M |
| 193 | CADL | Candel Therapeutics, Inc. | 700.46M | -3.04% | 1,011,915 | - |
| 194 | DRUG | Bright Minds Biosciences Inc. | 697.64M | 0.06% | 345,921 | - |
| 195 | NGNE | Neurogene Inc. | 695.45M | -1.88% | 161,731 | 925.00K |
| 196 | SGP | SpyGlass Pharma, Inc. | 685.05M | -1.87% | 103,814 | - |
| 197 | RIGL | Rigel Pharmaceuticals, Inc. | 679.77M | -0.22% | 485,297 | 299.77M |
| 198 | CBIO | Crescent Biopharma, Inc. | 673.58M | -4.29% | 272,863 | 11.88M |
| 199 | OCS | Oculis Holding AG | 672.12M | -2.71% | 375,459 | 1.40M |
| 200 | GYRE | Gyre Therapeutics, Inc. | 662.24M | -1.16% | 33,768 | 117.05M |
| 201 | ACHV | Achieve Life Sciences, Inc. | 626.22M | -1.13% | 926,995 | - |
| 202 | MDXG | MiMedx Group, Inc. | 625.57M | 1.69% | 531,892 | 389.42M |
| 203 | CRMD | CorMedix Inc. | 617.42M | -2.24% | 628,686 | 400.05M |
| 204 | AGMB | AgomAb Therapeutics NV | 616.09M | -3.32% | 59,096 | - |
| 205 | NVCT | Nuvectis Pharma, Inc. | 608.76M | -4.17% | 248,222 | - |
| 206 | IMMX | Immix Biopharma, Inc. | 606.54M | -3.18% | 2,318,718 | - |
| 207 | ALLO | Allogene Therapeutics, Inc. | 600.57M | -4.40% | 4,874,170 | 22.00K |
| 208 | RGNX | REGENXBIO Inc. | 600.37M | -5.07% | 974,179 | 87.82M |
| 209 | SPRY | ARS Pharmaceuticals, Inc. | 589.86M | -1.00% | 3,484,923 | 98.99M |
| 210 | TECX | Tectonic Therapeutic, Inc. | 573.06M | -3.92% | 98,320 | - |
| 211 | STTK | Shattuck Labs, Inc. | 569.74M | 4.80% | 1,466,467 | 1.00M |
| 212 | ZVRA | Zevra Therapeutics, Inc. | 563.07M | -23.92% | 6,940,003 | 122.29M |
| 213 | RLMD | Relmada Therapeutics, Inc. | 543.33M | -0.38% | 1,650,486 | - |
| 214 | ALT | Altimmune, Inc. | 538.69M | -2.46% | 1,911,556 | 36.00K |
| 215 | PRME | Prime Medicine, Inc. | 532.82M | -0.67% | 2,377,949 | 4.03M |
| 216 | VSTM | Verastem, Inc. | 531.64M | -2.10% | 2,529,732 | 49.59M |
| 217 | FDMT | 4D Molecular Therapeutics, Inc. | 526.42M | -2.99% | 682,419 | 88.24M |
| 218 | CTNM | Contineum Therapeutics, Inc. | 525.65M | -2.16% | 122,841 | - |
| 219 | RZLT | Rezolute, Inc. | 521.29M | -6.03% | 1,146,889 | - |
| 220 | SLN | Silence Therapeutics plc | 520.52M | -3.76% | 341,873 | 839.00K |
| 221 | ARVN | Arvinas, Inc. | 518.11M | -1.11% | 385,661 | 89.40M |
| 222 | SLBT | SL Science Holding Limited | 504.27M | -1.58% | 286,722 | 3.36M |
| 223 | ANL | Adlai Nortye Ltd. | 500.00M | -5.45% | 130,694 | 5.00M |
| 224 | ZURA | Zura Bio Limited | 496.84M | -1.13% | 366,090 | - |
| 225 | ASMB | Assembly Biosciences, Inc. | 491.86M | 1.31% | 142,148 | 71.10M |
| 226 | ARTV | Artiva Biotherapeutics, Inc. | 487.34M | -0.99% | 567,954 | 251.00K |
| 227 | EIKN | Eikon Therapeutics, Inc. | 481.83M | -7.48% | 249,012 | - |
| 228 | DNA | Ginkgo Bioworks Holdings, Inc. | 480.79M | -7.19% | 771,156 | 151.40M |
| 229 | HELP | Cybin Inc. | 472.32M | -1.42% | 1,230,799 | - |
| 230 | PRTA | Prothena Corporation plc | 458.09M | 2.58% | 576,837 | 57.94M |
| 231 | VALN | Valneva SE | 455.82M | - | 6,232 | 180.25M |
| 232 | IKT | Inhibikase Therapeutics, Inc. | 455.33M | - | 2,158,411 | 1.00 |
| 233 | PROK | ProKidney Corp. | 453.09M | -1.32% | 1,716,911 | 889.00K |
| 234 | KYTX | Kyverna Therapeutics, Inc. | 450.49M | 1.65% | 850,892 | - |
| 235 | BIOT | Instinct Brothers Co., Ltd. | 446.65M | - | 44,124 | - |
| 236 | CABA | Cabaletta Bio, Inc. | 438.62M | -1.10% | 1,662,347 | - |
| 237 | SGMT | Sagimet Biosciences Inc. | 436.59M | 0.86% | 910,897 | - |
| 238 | OVID | Ovid Therapeutics Inc. | 434.87M | -2.92% | 984,942 | 7.12M |
| 239 | LRMR | Larimar Therapeutics, Inc. | 417.53M | -0.25% | 1,230,901 | - |
| 240 | OCGN | Ocugen, Inc. | 409.61M | -4.72% | 4,119,147 | 4.47M |
| 241 | EVMN | Evommune, Inc. | 409.17M | 0.35% | 274,130 | 10.00M |
| 242 | PBYI | Puma Biotechnology, Inc. | 406.18M | -0.37% | 205,692 | 227.18M |
| 243 | EDIT | Editas Medicine, Inc. | 399.00M | -4.76% | 1,515,551 | 38.69M |
| 244 | BNTC | Benitec Biopharma Inc. | 394.04M | 0.26% | 161,893 | - |
| 245 | AUTL | Autolus Therapeutics plc | 385.91M | -4.61% | 716,974 | 92.62M |
| 246 | VTVT | vTv Therapeutics Inc. | 381.34M | -2.94% | 176,022 | 36.84M |
| 247 | EPRX | Eupraxia Pharmaceuticals Inc. | 381.30M | -7.78% | 892,500 | - |
| 248 | SCTX | Scribe Therapeutics Inc. | 381.30M | 44.33% | 990,795 | 36.28M |
| 249 | IPSC | Century Therapeutics, Inc. | 380.55M | -2.76% | 678,432 | 109.16M |
| 250 | PRLD | Prelude Therapeutics Incorporated | 379.85M | -2.54% | 284,205 | 16.72M |
| 251 | STRO | Sutro Biopharma, Inc. | 379.13M | -3.05% | 327,979 | 99.61M |
| 252 | AVIR | Atea Pharmaceuticals, Inc. | 378.53M | -0.42% | 381,460 | - |
| 253 | CCCC | C4 Therapeutics, Inc. | 375.93M | -6.85% | 2,583,883 | 34.86M |
| 254 | CMPX | Compass Therapeutics, Inc. | 372.78M | -2.36% | 1,589,937 | 850.00K |
| 255 | ENTA | Enanta Pharmaceuticals, Inc. | 371.62M | -1.31% | 104,646 | 69.21M |
| 256 | LXEO | Lexeo Therapeutics, Inc. | 365.91M | -1.06% | 656,868 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 363.13M | -3.51% | 571,350 | 9.01M |
| 258 | DMAC | DiaMedica Therapeutics Inc. | 362.90M | -1.25% | 177,070 | - |
| 259 | UPB | Upstream Bio, Inc. | 348.83M | 0.16% | 626,416 | 3.32M |
| 260 | RCKT | Rocket Pharmaceuticals, Inc. | 348.33M | -2.74% | 1,154,713 | - |
| 261 | FENC | Fennec Pharmaceuticals Inc. | 347.02M | -1.58% | 90,005 | 51.00M |
| 262 | ABEO | Abeona Therapeutics Inc. | 344.82M | -5.17% | 1,171,889 | 14.54M |
| 263 | PALI | Palisade Bio, Inc. | 338.48M | -3.47% | 2,333,432 | - |
| 264 | VCRE | Vicore Pharma Holding AB (publ) | 325.67M | -0.09% | 2,114 | 370.61K |
| 265 | VNDA | Vanda Pharmaceuticals Inc. | 311.50M | -3.36% | 768,868 | 217.78M |
| 266 | LYEL | Lyell Immunopharma, Inc. | 309.49M | -1.17% | 90,651 | 31.00K |
| 267 | ZNTL | Zentalis Pharmaceuticals, Inc. | 308.24M | -2.70% | 1,212,284 | 26.87M |
| 268 | INDP | Indaptus Therapeutics, Inc. | 295.56M | -5.78% | 55,678 | - |
| 269 | OABI | OmniAb, Inc. | 294.29M | -0.49% | 320,630 | 28.94M |
| 270 | FHTX | Foghorn Therapeutics Inc. | 284.76M | -4.34% | 122,069 | 28.22M |
| 271 | FATE | Fate Therapeutics, Inc. | 280.91M | -4.37% | 1,044,434 | 6.32M |
| 272 | IMRX | Immuneering Corporation | 279.49M | -1.59% | 465,178 | - |
| 273 | ELDN | Eledon Pharmaceuticals, Inc. | 276.74M | -4.28% | 1,280,049 | - |
| 274 | NMRA | Neumora Therapeutics, Inc. | 276.07M | -4.49% | 665,685 | - |
| 275 | ALXO | ALX Oncology Holdings Inc. | 273.16M | 0.50% | 1,011,351 | - |
| 276 | BCYC | Bicycle Therapeutics plc | 270.17M | -6.97% | 572,862 | 63.50M |
| 277 | SABS | SAB Biotherapeutics, Inc. | 268.39M | -1.96% | 954,234 | 114.70K |
| 278 | SLGL | Sol-Gel Technologies Ltd. | 267.93M | 1.75% | 24,515 | 18.47M |
| 279 | AGEN | Agenus Inc. | 267.62M | -3.39% | 1,249,283 | 123.87M |
| 280 | OTLK | Outlook Therapeutics, Inc. | 262.73M | 6.44% | 57,888,076 | 333.14K |
| 281 | QTTB | Q32 Bio Inc. | 256.89M | -1.50% | 178,771 | 53.74M |
| 282 | LCTX | Lineage Cell Therapeutics, Inc. | 256.78M | -3.74% | 1,230,874 | 14.78M |
| 283 | IFRX | InflaRx N.V. | 256.29M | 0.58% | 823,297 | 33.82K |
| 284 | NAGE | Niagen Bioscience, Inc. | 256.19M | 0.63% | 462,723 | 130.42M |
| 285 | TTRX | Turn Therapeutics Inc. | 254.39M | -9.92% | 99,619 | - |
| 286 | IRD | Opus Genetics, Inc. | 254.30M | 5.48% | 1,089,491 | 11.98M |
| 287 | FULC | Fulcrum Therapeutics, Inc. | 247.88M | -1.06% | 572,842 | 80.00M |
| 288 | PRQR | ProQR Therapeutics N.V. | 242.73M | -3.91% | 567,931 | 15.73M |
| 289 | MGNX | MacroGenics, Inc. | 235.18M | -7.73% | 2,653,931 | 157.08M |
| 290 | RNAC | Cartesian Therapeutics, Inc. | 231.53M | -0.51% | 143,286 | 1.78M |
| 291 | CNXU | Conexeu Sciences Inc. | 229.32M | -6.34% | 61,901 | - |
| 292 | SRZN | Surrozen, Inc. | 229.07M | -6.76% | 184,250 | 7.49M |
| 293 | GALT | Galectin Therapeutics Inc. | 228.52M | 0.58% | 313,363 | - |
| 294 | TARA | Protara Therapeutics, Inc. | 225.94M | -0.50% | 434,455 | - |
| 295 | OBIO | Orchestra BioMed Holdings, Inc. | 223.95M | 2.75% | 149,341 | 32.72M |
| 296 | AVXL | Anavex Life Sciences Corp. | 222.41M | -3.23% | 1,012,548 | - |
| 297 | ACIU | AC Immune SA | 221.22M | -0.45% | 384,396 | 4.62M |
| 298 | CHRS | Coherus Oncology, Inc. | 217.49M | -1.40% | 445,478 | 46.88M |
| 299 | CGEN | Compugen Ltd. | 215.65M | -2.56% | 200,166 | 72.66M |
| 300 | NAUT | Nautilus Biotechnology, Inc. | 214.76M | -4.52% | 623,095 | - |
| 301 | CLLS | Cellectis S.A. | 214.26M | 2.53% | 23,673 | 75.11M |
| 302 | ADAG | Adagene Inc. | 211.43M | -5.04% | 127,525 | 7.67M |
| 303 | TRDA | Entrada Therapeutics, Inc. | 210.80M | -3.31% | 566,134 | 5.74M |
| 304 | NBP | NovaBridge Biosciences | 204.70M | - | 199,379 | - |
| 305 | WHWK | Whitehawk Therapeutics, Inc. | 199.54M | -3.13% | 407,805 | 7.15M |
| 306 | KROS | Keros Therapeutics, Inc. | 199.11M | -0.79% | 140,634 | 33.18M |
| 307 | RNA | Atrium Therapeutics, Inc. | 196.54M | -3.53% | 120,858 | 36.68M |
| 308 | PLX | Protalix BioTherapeutics, Inc. | 190.95M | - | 211,725 | 76.38M |
| 309 | GLSI | Greenwich LifeSciences, Inc. | 190.52M | -1.59% | 113,799 | - |
| 310 | NERV | Minerva Neurosciences, Inc. | 188.22M | -9.21% | 172,721 | - |
| 311 | DTIL | Precision BioSciences, Inc. | 188.10M | -0.55% | 192,245 | 45.07M |
| 312 | VYGR | Voyager Therapeutics, Inc. | 187.31M | 0.32% | 483,013 | 36.49M |
| 313 | MDWD | MediWound Ltd. | 182.89M | -0.28% | 45,522 | 14.48M |
| 314 | IMUX | Immunic, Inc. | 182.39M | -6.23% | 155,828 | - |
| 315 | IVVD | Invivyd, Inc. | 180.12M | 0.36% | 3,066,330 | 55.87M |
| 316 | ANTX | AN2 Therapeutics, Inc. | 177.20M | - | 128,469 | - |
| 317 | MENS | Jyong Biotech Ltd. | 175.19M | -12.92% | 57,960 | - |
| 318 | NGEN | NervGen Pharma Corp. | 173.11M | -2.69% | 569,091 | - |
| 319 | ACOG | Alpha Cognition Inc. | 172.02M | -4.01% | 29,283 | 10.83M |
| 320 | LENZ | LENZ Therapeutics, Inc. | 171.82M | 8.51% | 1,429,504 | 20.99M |
| 321 | ARMP | Armata Pharmaceuticals, Inc. | 171.07M | -10.73% | 63,494 | 5.20M |
| 322 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 169.90M | -1.61% | 172,580 | - |
| 323 | IPHA | Innate Pharma S.A. | 169.81M | 1.14% | 2,543 | 10.57M |
| 324 | HUMA | Humacyte, Inc. | 168.47M | -2.16% | 2,566,399 | 2.02M |
| 325 | TNYA | Tenaya Therapeutics, Inc. | 168.17M | 0.25% | 1,795,665 | 225.00K |
| 326 | KPTI | Karyopharm Therapeutics Inc. | 167.93M | 4.51% | 900,096 | 151.12M |
| 327 | OKUR | OnKure Therapeutics, Inc. | 166.43M | -2.37% | 186,005 | - |
| 328 | PYXS | Pyxis Oncology, Inc. | 165.36M | -2.61% | 854,805 | 13.86M |
| 329 | ORMP | Oramed Pharmaceuticals Inc. | 164.93M | -3.12% | 134,461 | 2.00M |
| 330 | ALEC | Alector, Inc. | 164.32M | -0.67% | 325,293 | 18.42M |
| 331 | CAMP | Camp4 Therapeutics Corporation | 164.09M | 4.98% | 169,582 | 3.93M |
| 332 | NKTX | Nkarta, Inc. | 162.41M | -1.30% | 699,207 | - |
| 333 | MIST | Milestone Pharmaceuticals Inc. | 157.82M | -3.33% | 873,914 | 1.78M |
| 334 | YDES | YD Bio Limited | 157.52M | 9.80% | 83,074 | 510.36K |
| 335 | TNXP | Tonix Pharmaceuticals Holding Corp. | 157.50M | -6.97% | 715,085 | 17.56M |
| 336 | EQ | Equillium, Inc. | 157.43M | -7.43% | 197,934 | 4.39M |
| 337 | ARCT | Arcturus Therapeutics Holdings Inc. | 157.18M | -4.49% | 432,816 | 54.71M |
| 338 | NRXP | NRx Pharmaceuticals, Inc. | 157.16M | -8.76% | 791,603 | 2.29M |
| 339 | CRBU | Caribou Biosciences, Inc. | 155.71M | -3.68% | 946,832 | 11.20M |
| 340 | ABOS | Acumen Pharmaceuticals, Inc. | 153.84M | -1.84% | 226,078 | - |
| 341 | KRRO | Korro Bio, Inc. | 153.46M | -7.72% | 146,972 | 3.84M |
| 342 | CNTN | Canton Strategic Holdings, Inc. | 149.62M | -5.83% | 774,890 | - |
| 343 | UNCY | Unicycive Therapeutics, Inc. | 147.92M | -1.10% | 496,979 | - |
| 344 | MOLN | Molecular Partners AG | 146.04M | -2.02% | 1,047 | 856.30K |
| 345 | KZIA | Kazia Therapeutics Limited | 140.09M | -5.98% | 317,923 | 1.27M |
| 346 | AARD | Aardvark Therapeutics, Inc. | 137.88M | -1.10% | 121,859 | - |
| 347 | CUE | Cue Biopharma, Inc. | 134.92M | -2.93% | 148,255 | 32.73M |
| 348 | CNTB | Connect Biopharma Holdings Limited | 134.74M | -2.73% | 327,905 | 233.00K |
| 349 | CDXS | Codexis, Inc. | 134.53M | -25.63% | 10,376,854 | 78.09M |
| 350 | HURA | TuHURA Biosciences, Inc. | 134.37M | -1.86% | 204,190 | - |
| 351 | PEPG | PepGen Inc. | 133.50M | -8.10% | 734,994 | - |
| 352 | CBUS | Cibus, Inc. | 129.76M | -4.49% | 94,641 | 4.29M |
| 353 | GNLX | Genelux Corporation | 128.34M | -2.36% | 153,708 | 8.00K |
| 354 | ANIX | Anixa Biosciences, Inc. | 125.89M | -1.33% | 339,198 | - |
| 355 | GUTS | Fractyl Health, Inc. | 122.64M | 2.15% | 1,767,165 | 3.00K |
| 356 | ENGN | enGene Therapeutics Inc. | 121.92M | -3.70% | 665,801 | - |
| 357 | SPRB | Spruce Biosciences, Inc. | 118.57M | -4.25% | 106,560 | 697.00K |
| 358 | TLSA | Tiziana Life Sciences Ltd | 115.41M | -12.50% | 328,809 | - |
| 359 | FBIO | Fortress Biotech, Inc. | 110.95M | -2.62% | 414,439 | 66.16M |
| 360 | VANI | Vivani Medical, Inc. | 110.38M | -7.91% | 203,149 | - |
| 361 | PMN | ProMIS Neurosciences, Inc. | 109.41M | -3.25% | 92,291 | - |
| 362 | SEER | Seer, Inc. | 108.31M | -3.90% | 521,907 | 15.17M |
| 363 | RANI | Rani Therapeutics Holdings, Inc. | 105.41M | -4.39% | 1,443,410 | 3.17M |
| 364 | ENTX | Entera Bio Ltd. | 101.04M | -3.76% | 163,295 | 42.00K |
| 365 | BDTX | Black Diamond Therapeutics, Inc. | 100.85M | -4.35% | 623,287 | 70.00M |
| 366 | ICCC | ImmuCell Corporation | 99.79M | 0.91% | 8,672 | 29.93M |
| 367 | COYA | Coya Therapeutics, Inc. | 99.69M | -2.97% | 159,104 | 7.94M |
| 368 | PLYX | Polaryx Therapeutics, Inc. | 97.05M | -2.84% | 90,088 | - |
| 369 | ONCY | Oncolytics Biotech Inc. | 96.94M | -4.26% | 827,623 | - |
| 370 | ALDX | Aldeyra Therapeutics, Inc. | 91.69M | -1.94% | 1,126,283 | - |
| 371 | BMEA | Biomea Fusion, Inc. | 90.37M | -0.79% | 398,410 | - |
| 372 | PTHS | Pelthos Therapeutics Inc. | 90.09M | -8.73% | 206,211 | 27.70M |
| 373 | NTHI | NeOnc Technologies Holdings, Inc. | 88.95M | -5.51% | 55,991 | 39.99K |
| 374 | KLRS | Kalaris Therapeutics, Inc. | 88.75M | -4.85% | 156,949 | - |
| 375 | RLYB | Rallybio Corporation | 86.41M | -0.49% | 41,588 | 858.00K |
| 376 | HRTX | Heron Therapeutics, Inc. | 86.27M | -0.70% | 1,159,345 | 150.71M |
| 377 | VRCA | Verrica Pharmaceuticals Inc. | 86.24M | -7.72% | 16,746 | 37.16M |
| 378 | ATHE | Alterity Therapeutics Limited | 85.18M | -3.20% | 17,856 | 4.43M |
| 379 | CSBR | Champions Oncology, Inc. | 85.13M | 2.17% | 11,285 | 57.95M |
| 380 | NRXS | NeurAxis, Inc. | 84.21M | -3.00% | 36,685 | 4.28M |
| 381 | CGTX | Cognition Therapeutics, Inc. | 82.29M | -4.24% | 451,326 | - |
| 382 | ACET | Adicet Bio, Inc. | 81.80M | -7.48% | 71,154 | - |
| 383 | OKYO | OKYO Pharma Limited | 81.34M | 4.73% | 45,726 | - |
| 384 | INO | Inovio Pharmaceuticals, Inc. | 79.81M | -4.89% | 3,719,690 | 65.34K |
| 385 | TELO | Telomir Pharmaceuticals, Inc. | 79.09M | -0.86% | 82,137 | - |
| 386 | ALPS | Alps Group Inc | 77.58M | -1.08% | 38,728 | 3.74M |
| 387 | MAIA | MAIA Biotechnology, Inc. | 75.39M | -3.13% | 404,718 | - |
| 388 | PYPD | PolyPid Ltd. | 74.78M | -8.02% | 286,400 | - |
| 389 | GANX | Gain Therapeutics, Inc. | 74.64M | -3.85% | 471,962 | - |
| 390 | RNTX | Rein Therapeutics Inc. | 73.62M | -1.10% | 342,088 | - |
| 391 | ATRA | Atara Biotherapeutics, Inc. | 71.18M | -3.30% | 75,218 | 23.14M |
| 392 | IBIO | iBio, Inc. | 71.04M | 2.14% | 1,213,322 | 300.00K |
| 393 | ANVS | Annovis Bio, Inc. | 70.62M | -5.14% | 1,034,212 | - |
| 394 | ELTX | Elicio Therapeutics, Inc. | 70.36M | -4.76% | 247,468 | - |
| 395 | LONA | LeonaBio, Inc. | 69.42M | 2.07% | 9,195 | - |
| 396 | XBIT | XBiotech Inc. | 69.21M | -0.44% | 22,160 | - |
| 397 | SPRO | Spero Therapeutics, Inc. | 68.90M | 2.59% | 11,767,489 | 61.19M |
| 398 | ACRV | Acrivon Therapeutics, Inc. | 68.48M | -4.19% | 257,803 | - |
| 399 | OSTX | OS Therapies Incorporated | 67.70M | -2.56% | 240,713 | - |
| 400 | ENLV | Enlivex Ltd. | 67.49M | -3.67% | 106,558 | - |
| 401 | PLRX | Pliant Therapeutics, Inc. | 67.49M | 0.93% | 307,551 | - |
| 402 | GOSS | Gossamer Bio, Inc. | 66.48M | -4.56% | 10,925,773 | 55.54M |
| 403 | PMVP | PMV Pharmaceuticals, Inc. | 66.13M | -6.77% | 131,918 | - |
| 404 | MNOV | MediciNova, Inc. | 64.97M | 0.76% | 26,778 | 596.64K |
| 405 | HYFT | MindWalk Holdings Corp. | 63.53M | 15.25% | 983,424 | 11.43M |
| 406 | IMA | ImageneBio, Inc. | 63.05M | 0.36% | 9,244 | 800.00K |
| 407 | CING | Cingulate Inc. | 62.50M | -4.13% | 78,013 | - |
| 408 | BOLD | Boundless Bio, Inc. | 57.73M | 1.98% | 194,546 | - |
| 409 | CRDF | Cardiff Oncology, Inc. | 56.54M | -1.34% | 1,200,851 | 525.00K |
| 410 | CNTX | Context Therapeutics Inc. | 56.42M | 3.68% | 2,085,792 | - |
| 411 | INKT | MiNK Therapeutics, Inc. | 55.15M | 6.85% | 20,350 | - |
| 412 | TCRX | TScan Therapeutics, Inc. | 51.89M | -6.19% | 1,063,116 | 9.14M |
| 413 | XLO | Xilio Therapeutics, Inc. | 51.75M | 4.09% | 20,074 | 53.48M |
| 414 | DWTX | Dogwood Therapeutics, Inc. | 50.44M | -2.60% | 18,786 | - |
| 415 | IMMP | Immutep Limited | 49.47M | -2.01% | 226,761 | 5.28M |
| 416 | TIL | Instil Bio, Inc. | 48.36M | -0.97% | 11,045 | - |
| 417 | ELOX | Eloxx Pharmaceuticals, Inc. | 48.19M | -0.50% | 93,117 | - |
| 418 | MCRB | Seres Therapeutics, Inc. | 48.08M | -5.07% | 84,526 | 1.15M |
| 419 | IBO | Impact BioMedical Inc. | 47.44M | 2.25% | 13,665 | 39.00K |
| 420 | RADX | Radiopharm Theranostics Limited | 47.20M | -17.25% | 1,535,949 | 10.86M |
| 421 | EDSA | Edesa Biotech, Inc. | 46.68M | -7.24% | 51,390 | - |
| 422 | ATYR | aTyr Pharma, Inc. | 46.41M | -4.98% | 825,921 | 190.00K |
| 423 | BYSI | BeyondSpring Inc. | 46.05M | 3.70% | 36,014 | 1.88M |
| 424 | MREO | Mereo BioPharma Group plc | 45.94M | -1.10% | 389,497 | 500.00K |
| 425 | VRXA | Veraxa Biotech AG | 45.39M | -3.23% | 176,581 | - |
| 426 | MGX | Metagenomi Therapeutics, Inc. | 45.36M | -1.23% | 65,895 | 22.33M |
| 427 | DYAI | Dyadic International, Inc. | 43.36M | -1.65% | 105,013 | 3.81M |
| 428 | INMB | INmune Bio Inc. | 43.07M | -5.81% | 186,094 | 50.00K |
| 429 | FLNA | Filana Therapeutics, Inc. | 43.04M | -4.43% | 262,186 | - |
| 430 | APLM | Apollomics, Inc. | 39.99M | -3.45% | 13,124 | 8.84M |
| 431 | EXOZ | eXoZymes, Inc. | 39.94M | 0.21% | 5,836 | -700.00 |
| 432 | RNXT | RenovoRx, Inc. | 39.02M | 1.26% | 148,218 | 1.49M |
| 433 | HYPD | Hyperion DeFi, Inc. | 38.05M | -4.92% | 268,024 | 1.04M |
| 434 | PDSB | PDS Biotechnology Corporation | 38.03M | -2.73% | 202,049 | - |
| 435 | GRCE | Grace Therapeutics, Inc. | 37.92M | -0.85% | 127,086 | - |
| 436 | GNTA | Genenta Science S.p.A. | 37.51M | -3.64% | 48,322 | - |
| 437 | NTRB | Nutriband Inc. | 36.22M | 1.71% | 21,825 | 1.80M |
| 438 | VERU | Veru Inc. | 36.11M | -2.60% | 101,713 | 16.89M |
| 439 | CRVO | CervoMed Inc. | 35.98M | -0.37% | 118,076 | 2.09M |
| 440 | LTRN | Lantern Pharma Inc. | 35.09M | -4.18% | 63,699 | - |
| 441 | NNVC | NanoViricides, Inc. | 33.71M | -3.27% | 314,427 | - |
| 442 | LITS | Lite Strategy, Inc. | 33.63M | -0.34% | 161,968 | - |
| 443 | ESLA | Estrella Immunopharma, Inc. | 33.57M | 2.04% | 78,743 | - |
| 444 | BCTX | BriaCell Therapeutics Corp. | 31.07M | -3.76% | 63,872 | - |
| 445 | SER | Serina Therapeutics, Inc. | 31.04M | -0.96% | 44,323 | 130.00K |
| 446 | ABVC | ABVC BioPharma, Inc. | 29.06M | -4.17% | 84,434 | 797.92K |
| 447 | KYNB | Kyntra Bio, Inc. | 28.46M | -0.57% | 2,690 | 7.44M |
| 448 | ACTU | Actuate Therapeutics, Inc. | 28.23M | -6.35% | 93,394 | - |
| 449 | PLRZ | Polyrizon Ltd. | 27.48M | -4.11% | 120,366 | - |
| 450 | ATNM | Actinium Pharmaceuticals, Inc. | 26.98M | -3.48% | 113,353 | 90.00K |
| 451 | IGC | IGC Pharma, Inc. | 26.42M | -0.38% | 202,343 | 1.11M |
| 452 | PSTV | Plus Therapeutics, Inc. | 26.36M | 1.32% | 67,553 | 5.18M |
| 453 | ALGS | Aligos Therapeutics, Inc. | 25.25M | -13.01% | 203,098 | 4.71M |
| 454 | EVAX | Evaxion A/S | 24.69M | -2.95% | 3,354 | 7.53M |
| 455 | BRNS | Barinthus Biotherapeutics plc | 24.59M | 0.32% | 17,143 | 14.97M |
| 456 | TVRD | Tvardi Therapeutics, Inc. | 23.55M | -1.95% | 335,514 | - |
| 457 | SKYE | Skye Bioscience, Inc. | 22.91M | -3.42% | 45,968 | - |
| 458 | CELU | Celularity Inc. | 21.71M | -1.32% | 48,112 | 26.55M |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 21.28M | -8.08% | 161,001 | - |
| 460 | HOWL | Werewolf Therapeutics, Inc. | 20.75M | 18.55% | 2,988,462 | 1.14M |
| 461 | CVM | CEL-SCI Corporation | 20.62M | -0.84% | 144,919 | - |
| 462 | MRKR | Marker Therapeutics, Inc. | 20.34M | -3.94% | 57,908 | 3.55M |
| 463 | GRDX | GridAI Technologies Corp. | 20.23M | -9.25% | 256,894 | - |
| 464 | NCEL | NewcelX Ltd. | 20.22M | -1.18% | 6,083 | - |
| 465 | ATOS | Atossa Therapeutics, Inc. | 19.76M | -4.77% | 40,789 | - |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 19.67M | -7.14% | 392,787 | -13.27K |
| 467 | JSPR | Jasper Therapeutics, Inc. | 19.27M | -5.58% | 674,155 | - |
| 468 | CLRB | Cellectar Biosciences, Inc. | 19.26M | -2.43% | 36,030 | - |
| 469 | PLUR | Pluri Inc. | 19.21M | -0.84% | 9,358 | 1.08M |
| 470 | DARE | Daré Bioscience, Inc. | 19.17M | 1.59% | 197,166 | 1.16M |
| 471 | LGVN | Longeveron Inc. | 18.96M | -1.19% | 160,245 | 1.22M |
| 472 | TVGN | Tevogen Bio Holdings Inc. | 18.94M | 1.81% | 8,491 | - |
| 473 | ALLR | Allarity Therapeutics, Inc. | 18.93M | -2.46% | 43,887 | 345.00K |
| 474 | QNTM | Quantum BioPharma Ltd. | 18.17M | 5.28% | 37,163 | - |
| 475 | QNCX | Quince Therapeutics, Inc. | 17.46M | -2.32% | 14,884 | - |
| 476 | LPCN | Lipocine Inc. | 17.15M | -5.02% | 35,736 | 2.00M |
| 477 | PTN | Palatin Technologies, Inc. | 17.10M | -4.04% | 8,625 | 12.88M |
| 478 | VYNE | VYNE Therapeutics Inc. | 16.98M | -44.88% | 2,953,153 | 454.00K |
| 479 | PASG | Passage Bio, Inc. | 15.85M | 0.82% | 95,411 | - |
| 480 | NXTC | NextCure, Inc. | 15.32M | 1.44% | 282,275 | - |
| 481 | AKTX | Akari Therapeutics, Plc | 15.23M | -6.45% | 28,092 | - |
| 482 | LSTA | Lisata Therapeutics, Inc. | 15.21M | -21.23% | 133,686 | 170.00K |
| 483 | KTTA | Pasithea Therapeutics Corp. | 15.20M | -5.25% | 325,171 | - |
| 484 | ICU | SeaStar Medical Holding Corporation | 15.08M | 0.27% | 78,480 | 1.44M |
| 485 | MLEC | Moolec Science SA | 14.97M | 0.21% | 8,519 | 7.83M |
| 486 | CYCN | Cyclerion Therapeutics, Inc. | 14.84M | -3.31% | 73,368 | 1.99M |
| 487 | OSRH | OSR Health, Inc. | 14.84M | -6.04% | 270,268 | 2.63M |
| 488 | HIND | Vyome Holdings, Inc. | 14.46M | -3.74% | 9,732 | 152.72K |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 14.28M | -2.07% | 176,710 | 5.61M |
| 490 | LEXX | Lexaria Bioscience Corp. | 13.86M | -1.96% | 7,420 | 194.00K |
| 491 | TPST | Tempest Therapeutics, Inc. | 13.71M | -1.56% | 262,942 | - |
| 492 | BLRX | BioLineRx Ltd. | 12.91M | -1.40% | 2,697 | 1.40M |
| 493 | SNTI | Senti Biosciences Holdings, Inc. | 12.58M | -5.34% | 190,134 | 38.00K |
| 494 | COCP | Cocrystal Pharma, Inc. | 12.41M | -2.17% | 38,185 | 225.00K |
| 495 | PHIO | Phio Pharmaceuticals Corp. | 12.08M | -2.80% | 84,987 | - |
| 496 | INTS | Intensity Therapeutics, Inc. | 12.03M | 0.45% | 3,461 | - |
| 497 | CALC | CalciMedica, Inc. | 12.00M | 6.15% | 270,373 | - |
| 498 | INAB | IN8bio, Inc. | 11.82M | 0.84% | 30,214 | - |
| 499 | KALA | KALA BIO, Inc. | 11.79M | 3.92% | 127,932 | - |
| 500 | GDTC | CytoMed Therapeutics Limited | 11.71M | 12.50% | 3,256,767 | 669.28K |